IN8BIO, INC.
For the period ended Mar 31, 2025. Filed May 7, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 7, 2025
INAB$0.93+11.6%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Balance Sheets
(In thousands, except share and per share data)
| March 31, | ||
|---|---|---|
| 2025 | December 31, | |
| (unaudited) | 2024 | |
| Assets · (Note 2) | ||
| Current assets | ||
| Cash | $11,888 | $11,120 |
| Prepaid expenses and other current assets | 837 | 1,458 |
| Total Current Assets | 12,725 | 12,578 |
| Non-current assets | ||
| Property and equipment, net | 2,602 | 2,858 |
| Restricted cash | 269 | 266 |
| Right-of-use assets - finance leases | 828 | 1,068 |
| Right-of-use assets - operating leases | 3,170 | 3,899 |
| Other non-current assets | 275 | 275 |
| Total Non-Current Assets | 7,144 | 8,366 |
| Total Assets | $19,869 | $20,944 |
| Liabilities and Stockholders' Equity | ||
| Liabilities | ||
| Current liabilities | ||
| Accounts payable | $575 | $389 |
| Accrued expenses and other current liabilities | 1,145 | 1,047 |
| Short-term finance lease liability | 576 | 694 |
| Short-term operating lease liability | 661 | 953 |
| Total Current Liabilities | 2,957 | 3,083 |
| Long-term finance lease liability | 189 | 295 |
| Long-term operating lease liability | 2,846 | 3,088 |
| Total Non-Current Liabilities | 3,035 | 3,383 |
| Total Liabilities | 5,992 | 6,466 |
| Stockholders' Equity | ||
| Preferred stock, par value $0.0001 per share; 10,000,000 shares authorized at March 31, 2025 and December 31, 2024, respectively; no shares issued and outstanding | — | — |
| Common stock, par value $0.0001 per share; 490,000,000 shares authorized at March 31, 2025 and December 31, 2024; 81,258,763 and 72,483,253 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively | 8 | 7 |
| Additional paid-in capital | 141,075 | 136,127 |
| Accumulated deficit | (127,206) | (121,656) |
| Total Stockholders' Equity | 13,877 | 14,478 |
| Total Liabilities and Stockholders' Equity | $19,869 | $20,944 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.